Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts.

Cataplexy Classification Diagnosis Excessive daytime sleepiness Fatigue Hypersomnia Hypersomnolence MSLT Narcolepsy Sleep Sleep inertia

Journal

Sleep medicine reviews
ISSN: 1532-2955
Titre abrégé: Sleep Med Rev
Pays: England
ID NLM: 9804678

Informations de publication

Date de publication:
08 2020
Historique:
received: 04 08 2019
revised: 13 02 2020
accepted: 13 02 2020
pubmed: 21 4 2020
medline: 15 7 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

The aim of this European initiative is to facilitate a structured discussion to improve the next edition of the International Classification of Sleep Disorders (ICSD), particularly the chapter on central disorders of hypersomnolence. The ultimate goal for a sleep disorders classification is to be based on the underlying neurobiological causes of the disorders with clear implication for treatment or, ideally, prevention and or healing. The current ICSD classification, published in 2014, inevitably has important shortcomings, largely reflecting the lack of knowledge about the precise neurobiological mechanisms underlying the majority of sleep disorders we currently delineate. Despite a clear rationale for the present structure, there remain important limitations that make it difficult to apply in routine clinical practice. Moreover, there are indications that the current structure may even prevent us from gaining relevant new knowledge to better understand certain sleep disorders and their neurobiological causes. We suggest the creation of a new consistent, complaint driven, hierarchical classification for central disorders of hypersomnolence; containing levels of certainty, and giving diagnostic tests, particularly the MSLT, a weighting based on its specificity and sensitivity in the diagnostic context. We propose and define three diagnostic categories (with levels of certainty): 1/"Narcolepsy" 2/"Idiopathic hypersomnia", 3/"Idiopathic excessive sleepiness" (with subtypes).

Identifiants

pubmed: 32311642
pii: S1087-0792(20)30049-6
doi: 10.1016/j.smrv.2020.101306
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101306

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors do not have any conflicts of interest to disclose.

Auteurs

Gert Jan Lammers (GJ)

Sleep Wake Centre SEIN, Achterweg 5, Heemstede, the Netherlands; Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: g.j.lammers@lumc.nl.

Claudio L A Bassetti (CLA)

Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Neurology, Sechenov First State Medical University, Moscow, Russia.

Leja Dolenc-Groselj (L)

Institute of Clinical Neurophysiology, University Medical Centre, University of Ljubljana, Ljubljana, Slovenia.

Poul J Jennum (PJ)

Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.

Ulf Kallweit (U)

Center for Narcolepsy and Hypersomnias, University Witten/Herdecke, Witten, Germany.

Ramin Khatami (R)

Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Neurology, Sechenov First State Medical University, Moscow, Russia; Center for Sleep Medicine, Sleep Research and Epileptology, Klinik Barmelweid AG, Barmelweid, Switzerland.

Michel Lecendreux (M)

Pediatric Sleep Center, Hospital Robert-Debré, Paris, France; National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome (CNR Narcolepsie-hypersomnie), Paris, France.

Mauro Manconi (M)

Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Neurology, Sechenov First State Medical University, Moscow, Russia; Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Civic Hospital of Lugano, Lugano, Switzerland.

Geert Mayer (G)

Department of Neurology, Hephata Klinik & Philipps Universität Marburg, Germany.

Markku Partinen (M)

Helsinki Sleep Clinic, Vitalmed Research Centre, Helsinki, Finland; Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland.

Giuseppe Plazzi (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Paul J Reading (PJ)

Department of Neurology, James Cook University Hospital, Middlesbrough, UK.

Joan Santamaria (J)

Neurology Service, Multidisciplinary Sleep Unit, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Universitat de Barcelona, Barcelona, Spain.

Karel Sonka (K)

Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.

Yves Dauvilliers (Y)

Sleep-Wake Disorders Center, National Reference Network for Narcolepsy, Department of Neurology, Gui-de-Chauliac Hospital, INSERM, U1061, University of Montpellier, CHU Montpellier, France. Electronic address: ydauvilliers@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH